Clinical Study of DTX301 AAV-Mediated Gene Transfer for Ornithine Transcarbamylase (OTC) Deficiency
Clinical trial NCT05345171 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05345171
- Sponsor
- Ultragenyx Pharmaceutical Inc
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-18
- Primary completion
- 2027-09-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.